Effect of individualized exercise interventions versus control group on musculoskeletal disorders and quality of life in Parkinson's patients

Effect of individualized exercise interventions versus control group on musculoskeletal disorders and quality of life in Parkinson's patients: a randomized clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N519

Enrollment

Registered

2024-07-05

Start date

2024-07-22

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease. Parkinson's disease

Interventions

Intervention 1: Intervention group: Routine treatment plus the American College of Sports Medicine (ACSM) exercise protocol is given at home using a formula (Frequency, Intensity, Time, and Type) spec

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 30 to 65 years Parkinson's with mild to moderate functioning

Exclusion criteria

Exclusion criteria: Inability to do sports

Design outcomes

Primary

Measure	Time frame
Musculoskeletal disorders. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using the Nordic questionnaire.;Quality of life. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using the World Health Organization Quality of Life Summary Questionnaire (WHOQOL-BREF).;Cognitive performance. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using MoCA questionnaire.;Parkinson's severity. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using the Unified Parkinson's disease rating scale (UPDRS).	—

Measure

Time frame

Musculoskeletal disorders. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using the Nordic questionnaire.;Quality of life. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using the World Health Organization Quality of Life Summary Questionnaire (WHOQOL-BREF).;Cognitive performance. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using MoCA questionnaire.;Parkinson's severity. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Using the Unified Parkinson's disease rating scale (UPDRS).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMotahare Bagheri

Hamedan University of Medical Sciences

motahare.bgr@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026